¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Wiskott-Aldrich Syndrome Protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • obstructive sleep apnea syndrome
    Æó¼â¼ö¸é¹«È£ÈíÁõÈıº
  • overlap syndrome
    °ãħÁõÈıº, Áߺ¹ÁõÈıº
  • overuse syndrome
    °ú»ç¿ëÁõÈıº, °ú¿ëÁõÈıº
  • overwear syndrome
    °úµµÂø¿ëÁõÈıº
  • Pancoast syndrome
    ÆÒÄÚ½ºÆ®ÁõÈıº
  • Pickwickian syndrome
    ÇÈÀ¨ÁõÈıº
  • Pierre Robin syndrome
    ÇÇ¿¡¸£·Î¹ðÁõÈıº
  • placental transfusion syndrome
    ŹݼöÇ÷ÁõÈıº
  • polycystic ovarian syndrome
    ´Ù³¶³­¼ÒÁõÈıº
  • postmenopausal syndrome
    Æó°æÈÄÁõÈıº
  • post-myocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº
  • postnasal drip syndrome
    ÄÚµÚÈ帧ÁõÈıº, Èĺñ·çÁõÈıº
  • postpericardiotomy syndrome
    ½É³¶¸·Àý°³¼úÈÄÁõÈıº
  • postpolio syndrome
    ¼Ò¾Æ¸¶ºñÈÄÁõÈıº
  • Prader-Willi syndrome
    ÇÁ·¡´õ-Àª¸®ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • shock syndrome
    Ãæ°ÝÁõÈıº
  • short bowel syndrome
    ÀÛÀºÃ¢ÀÚÁõÈıº
  • shoulder-hand syndrome
    ¾î±ú¼ÕÁõÈıº
  • sleep apnea syndrome
    ¼ö¸é¹«È£ÈíÁõÈıº
  • sleep choking syndrome
    ¼ö¸éÁú½ÄÁõÈıº
  • somatizing syndrome
    ½ÅüȭÁõÈıº
  • stasis syndrome
    âÀÚÁ¤Ã¼ÁõÈıº
  • stiff-man syndrome
    ±ÙÀ°°­Á÷ÁõÈıº
  • stroke syndrome
    ÁßdzÁõÈıº
  • sudden infant death syndrome
    ¿µ¾Æ±Þ»çÁõÈıº
  • sudden manhood death syndrome
    ûÀå³â±Þ»çÁõÈıº
  • superior orbital fissure syndrome
    À§´«È®Æ´»õÁõÈıº
  • supine hypotensive syndrome
    ´©¿îÀÚ¼¼ÀúÇ÷¾ÐÁõÈıº
  • tabetic syndrome
    ¼Ò¸ðÁõÁõÈıº, Ÿº£½ºÁõÈıº
  • tarsal tunnel syndrome
    ¹ß¸ñ±¼ÁõÈıº, Á·±Ù°üÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • OSAS=obstructive sleep apnea syndrome
    Æó¼â¼º ¼ö¸é ¹«È£Èí ÁõÈıº
  • Oasthouse syndrome
    ¿À¿ì½ºÆ®ÇϿ콺ÁõÈıº
  • Othello syndrome
    ¿À¼¿·Î ÁõÈıº
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • PIE syndrome
    È£»ê±¸¼º Æóħ½À ÁõÈıº
  • PMS(postmenopausal syndrome)
    Æó°æ±â ÁõÈıº
  • PMS(premenstrual syndrome)
    ¿ù°æÀü ÁõÈıº
  • PMS.see premenstrual syndrome
    ¿ù°æÀüÁßÈıº(êÅÌèîññøý¦ÏØ)
  • Papillon-Lefervre syndrome
    ÆÄÇÇ¿ë-¸£Æäºê¸£ ÁõÈıº
  • Parinauds oculonoduler syndrome
    ÆÄ¸®³ë¾È ¸²ÇÁÀý ÁõÈıº.
  • Parinauds syndrome
    ÆÄ¸®³ëµåÁõÈıº
  • Peutz-Jeghers syndrome
    Ç»Ã÷Á¦°Å½ºÁõÈıº.
  • Peutz-Jeghers syndrome
    Æ÷ÀÌÃ÷-¿¹°ÅÁõÈıº.
  • Pickwickian syndrome
    ÇÇÅ©À§Å© ÁõÈıº
  • Plummer Vinson syndrome
    Ç÷¯¸Ó-ºó¼ÕÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • aphasic and apraxic syndrome
    ½Ç¾î½ÇÇàÁõÈıº(ã÷åÞãùú¼ñøý¦ÏØ).
  • aqueous mis-direction syndrome
    ¹æ¼öÈ帧ÀÌ»óÁõÈıº
  • ards(adult respiratory disress syndrome)
    ARDS(¼ºÀÎÈ£Èí°ï¶õÁõÈıº)(à÷ìÑû¼ýåÍÝÑññøý¦ÏØ)
  • arthritis-dermatitis syndrome
    °üÀý¿°-ÇǺο° ÁõÈıº
  • ashermans syndrome
    ¾Æ¼Å¸¸ ÁõÈıº
  • asphyctic syndrome
    Áú½ÄÁõÈıº.
  • atomic bomb syndrome
    ¿ø(ÀÚ)Æø(ź)ÁõÈıº.
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³úÁõÈıº
  • atypical schizophrenic syndrome
    ºñÁ¤Çü Á¤½ÅºÐ¿­¼º ÁõÈıº
  • auriculotemporal nerve syndrome
    À̰³ÃøµÎ½Å°æÁõÈıº.
  • auriculotemporal syndrome
    À̰³ÃøµÎÁõÈıº(¡­ñøý¦ÏØ).
  • auriculotemporal syndrome
    À̰³ÃøµÎ ÁõÈıº(ì¼Ë¿ö°Ôé ñøý¦ÏØ)
  • bantis syndrome
    ¹ÝƼÁõÈıº(¡­ñøý¦ÏØ)
  • bartters syndrome
    ¹ÙÅÍ ÁõÈıº(¡­ñøý¦ÏØ)
  • basal cell nevus syndrome
    ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº(¡­Ù½Úèñøý¦ÏØ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
TBP bithionol; testosterone-binding protein; thyroxine-binding protein; total bypass; tributyl phosphate...
TCP T-complex protein; therapeutic continuous penicillin; total circulating protein; transcutaneous pace...
UPEP urinary protein electrophoresis; urine protein electrophoresis
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
DIC Disseminated intravascular coagulation syndrome
DS Down Syndrome
DRS Duane retraction syndrome
DJS Dubin Johnson Syndrome
DNS Dysplastic Naevus Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intermediate syndrome
    Áß°£Çü ÁõÈıº
  • iridocorneal-endothelial syndrome
    ȫä °¢¸· ³»ÇÇ ÁõÈıº
  • iris-nevus syndrome
    ȫä ¸ð¹Ý ÁõÈıº
  • irritation syndrome
    ÀÚ±Ø ÁõÈıº
  • jaw winking syndrome
    ÇÏ¾Ç À®Å© ÁõÈıº
  • jet lag syndrome
    ºñÇà ½ÃÂ÷ ÁõÈıº
  • Kast's syndrome
    Ä«½ºÆ® ÁõÈıº
    °ñ°ÝÀÇ ´Ù¹ß¼º ¿¬°ñÁ¾¿¡ ÇØ¸é»ó Ç÷°üÁ¾ÀÌ µû¸£´Â Áúº´.
  • Kearns-Sayre syndrome
    ÄÁ½º-¼¼À̾î ÁõÈıº
  • Kelly Paterson syndrome
    Ä̸®ÆäÅͽ¼ ÁõÈıº
  • kidney nephrotic syndrome
    ½Å ÁõÈıº
  • Kleinfelter syndrome
    Ŭ¶óÀÎÆçÅÍ ÁõÈıº
    1. 1942³â H.F. Ŭ¶óÀÎÆçÅͰ¡ ±âÀçÇÑ ¼º¿°»öü ÀÌ»ó ÁõÈıº. Á¤»óÀÎÀÇ ¼º¿°»öüÇüÀº ³²¼º XY, ¿©¼º XX¸¦ ³ªÅ¸³»Áö¸¸, ÀÌ ÁõÈıº¿¡¼­´Â ¼º¿°»öüÇüÀÌ XXY, XXYY, XXXXY µîÀÇ ¿©·¯ °¡Áö ÀÌ»óÇÑ ÇüŸ¦ ³ªÅ¸³½´Ù. ¿Ü¼º±â, ü°Ý, ¼ºÂ¡ µîÀÇ Æ¯Â¡ÀûÀÎ Áõ¼¼·Î º¼ ¶§¿¡ ¿ÏÀüÇÑ ³²¼ºÀÌ °áÈ¥ÇÏ¿© ¼º»ýȰ±îÁö ÇÏ¿´À¸³ª, ÀÚ½ÄÀÌ ¾øÀÚ ºÎºÎ°¡ ÇÔ²² º´¿øÀ» ã¾Æ°¡¼­ ¿°»öü¸¦ °Ë»çÇØ º¸°í ³²ÀÚ¿¡°Ô ÀÌ ÁõÈıºÀÌ ÀÖÀ½À» ¾Ë°Ô µÇ´Â °æ¿ì°¡ ¸¹´Ù. ÀÌ ¹Û¿¡ ¼ºÀÎÀÌ µÇ¾î ³ªÅ¸³ª´Â ÁÖ¿ä Áõ¼¼¸¦ µé¸é, ¼Ò°íȯ, ¿©¼ºÇü À¯¹æÁõ, ¹«Á¤ÀÚÁõ, ºÒÀÓ, ¿äÁß °í³ªµµÆ®·ÎÇÉ
  • Klippel Feil syndrome
    Ŭ¸®Æç ÆÄÀÏ ÁõÈıº, Ŭ¸®Æç-ÆäÀÏ ÁõÈıº
    °æÃß ¼öÀÇ °¨¼Ò ȤÀº ´Ù¹ß¼º ÆíÃø ôÃßÀÇ °ñ À¯ÇÕ¿¡ ±âÀÎÇÑ °æºÎÀÇ ´ÜÃà, °æºÎ ¿îµ¿ Àå¾Ö µîÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıº.
  • Korsakov syndrome
    ÄÚ¸£»çÄÚÇÁ ÁõÈıº
    ±â¾ï·ÂÀÇ Àå¾Ö, ½Ã°£Àû, °ø°£ÀûÀÎ ÁüÀÛÀÌ °ï¶õÇÑ ÁüÀÛ ÀǽÄÀÇ Àå¾Ö, °Ç¸Á, ÀÛ¾îÁõ µîÀÇ ¿©·¯ Áõ¼¼¸¦ ³ªÅ¸³»´Â ÁõÈıº. °Ç¸Á ÁõÈıºÀ̶ó°íµµ ÇÑ´Ù. ȯÀÚ´Â ½ÃÀÏÀ» Àؾî¹ö¸®°í Áö±Ý ¸· Áö³ª¿Â ±æµµ Àؾî¹ö¸®¸ç ±×³¯ÀÇ ½Ä»çÀÇ ³»¿ëÀ̳ª ¸éȸÀÚ µîµµ Àؾî¹ö¸®°í »ý°¢Çس»Áö ¸øÇÑ´Ù. ¶Ç ÁüÀÛ ÀǽÄÀÇ Àå¾Ö ¶§¹®¿¡ ÀڱⰡ ³õ¿© ÀÖ´Â ÇöÀçÀÇ »óȲµµ Á¤È®ÇÏ°Ô ÆÇ´ÜÇÏÁö ¸øÇÑ´Ù. Áú¹®¿¡ ´äÇÏ´Â ³»¿ëÀº °ø»óÀûÀ̰ųª ±× Àå¼ÒÀÇ Àڱؿ¡ ÃË¹ßµÇ¾î ¾Ö¸ÅÇÑ ¸»À» ÇÏ°Ô µÈ´Ù. ÀϹÝÀûÀ¸·Î Áö´É Àå¾Ö¸¦ ³ªÅ¸³»´Â ³ëÀμº Ä¡¸Å³ª ÁøÇึºñ ¿Ü¿¡, ¾ËÄÚ¿Ã Á¤½Åº´ µî¿¡¼­ º¼ ¼ö ÀÖÀ¸¸ç, µÎºÎ ¿Ü»óÀ̳ª ³ú Á¾¾ç µîÀÇ °æ¿ì¿¡µµ ³ªÅ¸³­´Ù.
  • Lacrimo-auriculo-dento-digital syndrome
    ´«¹° °ü ±Ó¹ÙÄû ÀÌ ¼Õ¹ß°¡¶ô ÁõÈıº
  • lacunar syndrome
    ¼Ò°ø¼º °æ»ö ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
protein NH2-terminal asparagine deamidase <enzyme> Converts amino terminal asparagine to aspartic acid; from porcine liver; mw about 33 kD
Registry number: EC 3.5.1.-
Synonym: porcine pnad
(26 Jun 1999)
protein-N-pi-phosphohistidine - sugar phosphotransferase <enzyme> Enzyme II of the system; leve is the the IIb subunit from bacillus subtilis
Registry number: EC 2.7.1.69
Synonym: phph-phosphotransferase, phosphohistidinoprotein-hexose phosphotransferase, leve gene product, IIb(lev)
(26 Jun 1999)
protein N-terminal acetyltransferase <enzyme> From saccharmyces cerevisiae; encodes a catalytic subunit of an n-terminal acetyltransferase; ard1 and nat1 proteins are subunits of this enzyme
Registry number: EC 2.3.1.-
Synonym: nat1 gene protein, saccharomyces, yeast protein n-terminal acetyltransferase, n-terminal protein acetyltransferase, ard1 protein
(26 Jun 1999)
herpes simplex virus protein vmw65 Trans-acting protein that combines with host factors to induce immediate early gene transcription in herpes simplex virus.
(12 Dec 1998)
protein o-methyltransferase <enzyme> An enzyme that catalyses the transfer of methyl groups from s-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters.
Chemical name: S-Adenosylmethionine:protein O-methyltransferase
Registry number: EC 2.1.1.-
(12 Dec 1998)
herpes simplex virus type 1 UL13 protein kinase <enzyme> Phosphorylates icp22 and involved in the accumulation of alpha and gamma mrnas and proteins in the infected cells; aa sequence has been determined
Registry number: EC 2.7.1.-
Synonym: ul13 protein kinase, hsv-1, hsv-1 ul13 protein, hsv-1 ul13 pk, u(l)13 protein kinase, protein kinase ul13
(26 Jun 1999)
protein p16 Product of the p16 tumour suppressor gene, that acts as cyclin-dependent kinase inhibitor of cdk4.
(12 Dec 1998)
protein p34cdc2 Phosphoprotein with protein kinase activity that functions in the g2/m phase transition of the cell cycle. It is the catalytic subunit of the maturation-promoting factor and complexes with both cyclin a and cyclin b in mammalian cells. The maximal activity of p34cdc2 is achieved when it is fully dephosphorylated. Protein p34cdc2, the product of the cdc2 gene in schizosaccharomyces pombe, should not be confused with the unrelated product of the cdc2 gene in saccharomyces cerevisiae that forms the large subunit of DNA polymerase III.
(12 Dec 1998)
protein p53 Nuclear phosphoprotein encoded by the p53 gene (genes, p53) whose normal function is to control cell proliferation. A mutant or absent p53 protein has been found in leukaemia, osteosarcoma, lung cancer, and colourectal cancer.
(12 Dec 1998)
protein phosphatases A class of enzymes that catalyze the dephosphorylation of specific phosphorylated proteins.
(05 Mar 2000)
protein processing, post-translational Any of various enzymically catalyzed post-translational modifications of peptides or proteins in the cell of origin. These modifications include carboxylation, hydroxylation, acetylation, phosphorylation, methylation, glycosylation, oxidation-reduction, degradation and lysis, peptide bond formation, and changes in molecular weight and electrophoretic motility.
(12 Dec 1998)
protein-proline kinase <enzyme> Phosphorylates synapsin i; phosphorylation takes place on serine 20, which is flanked by two proline molecules; heterodimer of p34(cdc2)/p58(cyclin a)
Registry number: EC 2.7.10.-
Synonym: proline-directed protein kinase
(26 Jun 1999)
protein quotient The number obtained by dividing the quantity of globulin of the blood plasma by the quantity of albumin.
Respiratory quotient (R.Q.), the steady state ratio of carbon dioxide produced by tissue metabolism to oxygen consumed in the same metabolism; for the whole body, normally about 0.82 under basal conditions; in the steady state, the respiratory quotient is equal to the respiratory exchange ratio.
Synonym: respiratory coefficient.
(05 Mar 2000)
protein S Nitrogenous organic compounds, containing more than about 100 amino acid residues, molecular weight 8,000-200,000, in vegetable and animal matter. Proteins yield amino acids on hydrolysis and are foods assimilated as amino acids and reconstructed in the protoplasm.
(12 Dec 1998)
Previous: protein processing, post-translational, protein-proline kinase, protein quotientNext: protein S, protein s deficiency, protein sequencingprotein S
Vitamin K dependent cofactor.
(18 Nov 1997)
protein s deficiency An autosomal dominant disorder showing decreased levels of plasma protein s antigen or activity, associated with venous thrombosis and pulmonary embolism. Protein s is a vitamin k-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated protein c (also a vitamin k-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein c deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á